Ceribell fetches $35 mln Series B

Mountain View, California-based Ceribell Inc, a provider of a system that diagnoses and treats patients at risk for seizures, has secured $35 million in Series B financing. Optimas Capital Partners Fund and The Rise Fund led the round with participation from UCB and LivaNova.

ManagersNorth AmericaUSHealthcareBriefs